The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - LiDCO Group Plc

6 Nov 2020 16:22

RNS Number : 5689E
LiDCO Group Plc
06 November 2020
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Horace Joseph Leitch

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Horace Joseph Leitch

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

LiDCO Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

Opening Position

04.11.2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

16,806,183

 

6.88

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

 

16,806,183

 

6.88

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

06.11.2020

Contact name:

Giles Cumner

Telephone number*:

01481 750 795

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETUNRNRRSUARAA
Date   Source Headline
26th Jun 201212:40 pmRNSNotification of Major Interest in Shares
26th Jun 201212:40 pmRNSNotification of Major Interest in Shares
22nd Jun 20123:05 pmRNSExercise of Share Options
13th Jun 201211:55 amRNSResult of AGM
13th Jun 20127:00 amRNSLaunch of the LiDCOrapid monitor in Japan
12th Jun 20127:00 amRNSAnnual Report and Accounts and Notice of AGM
29th May 20127:00 amRNSLiDCOrapid Registration in Japan
10th May 20127:00 amRNSLiDCO technologies highlighted in NHS report
4th May 20127:00 amRNSExercise of Share Options
25th Apr 201210:40 amRNSGrant of share option
24th Apr 20127:00 amRNSPreliminary Results
28th Mar 20123:10 pmRNSExercise of Share Option
23rd Feb 20127:00 amRNSTrading Update and Notice of Results and AGM
8th Feb 20124:31 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
9th Jan 20127:00 amRNSLiDCO signs licensing agreement with CNSystems
12th Dec 20112:30 pmRNSExercise of a Share Option
7th Dec 20117:00 amRNSNHS Innovation Review
26th Oct 20117:00 amRNSInterim Results
12th Oct 20117:00 amRNSLiDCO monitor reduces surgical complications
24th Aug 201111:42 amRNSDirector/PDMR Shareholding
23rd Aug 20117:00 amRNSPre- close trading update
29th Jul 20117:00 amRNSExercise of Share Options
28th Jul 20117:00 amRNSNotice of Results
20th Jul 20113:25 pmRNSDirector's Holdings
14th Jul 20114:22 pmRNSExercise of a Share Option / Director's Holdings
14th Jul 20117:00 amRNSLiDCO signs agreement with ICU Medical, Inc
29th Jun 201111:45 amRNSResult of AGM
29th Jun 20117:00 amRNSJapanese Registration and Supply Agreement
1st Jun 20112:00 pmRNSPosting of Annual Report and Notice of AGM
17th May 20117:00 amRNSIssue of Equity
21st Apr 201111:45 amRNSDirector/PDMR Shareholding
20th Apr 20114:20 pmRNSDirector/PDMR Shareholding
19th Apr 20117:00 amRNSGrant of Share Options
18th Apr 20117:00 amRNSPreliminary Results
18th Apr 20117:00 amRNSDirectorate Change
15th Apr 201111:45 amRNSHolding(s) in Company
21st Mar 20117:00 amRNSDistribution Contract
24th Feb 20117:00 amRNSTrading Update and Notice of Results and AGM
26th Oct 20107:00 amRNSInterim Results
26th Oct 20107:00 amRNSInterim Results
15th Oct 20107:00 amRNSLiDCO monitors link with GE Healthcare
23rd Aug 20107:00 amRNSIssue of Equity
17th Aug 20102:50 pmRNSPre-Close Trading Update
12th Aug 20107:00 amRNSNotice of Results
12th Jul 20109:00 amRNSDirector's Share Transaction
2nd Jul 20107:00 amRNSLiDCO study day receives RCN accreditation
29th Jun 201011:40 amRNSResult of AGM
7th Jun 20101:30 pmRNS2010 Annual Report and Accounts & Notice of AGM
4th Jun 20107:00 amRNSDirectors dealings and grant of options
10th May 20107:00 amRNSMultiparameter monitoring reduces risk in surgery

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.